Abstract
The mosquito-borne West Nile virus (WNV) poses a great threat to public health as no vaccine or specific antiviral treatment is available. Exploring virus-host interactions, specifically host factors that are required for virus infection, is important for better understanding the biology, pathogenesis, and transmission of WNV. Such essential host factors may also represent antiviral targets. The development of CRISPR technology has provided a powerful and convenient tool to perturbate host gene expression, allowing for unbiased, genome-wide screens of host factors for virus infection. Here we describe the necessary steps for performing a CRISPR knockout screen, which can also be applied to other viruses, to identify host factors critical for WNV infection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Colpitts TM, Conway MJ, Montgomery RR, Fikrig E (2012) West Nile virus: biology, transmission, and human infection. Clin Microbiol Rev 25(4):635–648. https://doi.org/10.1128/CMR.00045-12
Chancey C, Grinev A, Volkova E, Rios M (2015) The global ecology and epidemiology of West Nile virus. Biomed Res Int 2015:376230. https://doi.org/10.1155/2015/376230
Chambers TJ, Hahn CS, Galler R, Rice CM (1990) Flavivirus genome organization, expression, and replication. Annu Rev Microbiol 44:649–688. https://doi.org/10.1146/annurev.mi.44.100190.003245
Uetz P, Hughes RE (2000) Systematic and large-scale two-hybrid screens. Curr Opin Microbiol 3(3):303–308. https://doi.org/10.1016/s1369-5274(00)00094-1
Ma-Lauer Y, Lei J, Hilgenfeld R, von Brunn A (2012) Virus-host interactomes – antiviral drug discovery. Curr Opin Virol 2(5):614–621. https://doi.org/10.1016/j.coviro.2012.09.003
Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, de Jong YP, Rice CM (2009) Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457(7231):882–886. https://doi.org/10.1038/nature07684
DeFilippis V, Raggo C, Moses A, Fruh K (2003) Functional genomics in virology and antiviral drug discovery. Trends Biotechnol 21(10):452–457. https://doi.org/10.1016/S0167-7799(03)00207-5
Carette JE, Guimaraes CP, Varadarajan M, Park AS, Wuethrich I, Godarova A, Kotecki M, Cochran BH, Spooner E, Ploegh HL, Brummelkamp TR (2009) Haploid genetic screens in human cells identify host factors used by pathogens. Science 326(5957):1231–1235. https://doi.org/10.1126/science.1178955
Puschnik AS, Majzoub K, Ooi YS, Carette JE (2017) A CRISPR toolbox to study virus-host interactions. Nat Rev Microbiol 15(6):351–364. https://doi.org/10.1038/nrmicro.2017.29
Paddison PJ, Silva JM, Conklin DS, Schlabach M, Li M, Aruleba S, Balija V, O’Shaughnessy A, Gnoj L, Scobie K, Chang K, Westbrook T, Cleary M, Sachidanandam R, McCombie WR, Elledge SJ, Hannon GJ (2004) A resource for large-scale RNA-interference-based screens in mammals. Nature 428(6981):427–431. https://doi.org/10.1038/nature02370
Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, Mao M, Li B, Cavet G, Linsley PS (2003) Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21(6):635–637. https://doi.org/10.1038/nbt831
Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, Mulherkar N, Kuehne AI, Kranzusch PJ, Griffin AM, Ruthel G, Dal Cin P, Dye JM, Whelan SP, Chandran K, Brummelkamp TR (2011) Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477(7364):340–343. https://doi.org/10.1038/nature10348
Jae LT, Raaben M, Herbert AS, Kuehne AI, Wirchnianski AS, Soh TK, Stubbs SH, Janssen H, Damme M, Saftig P, Whelan SP, Dye JM, Brummelkamp TR (2014) Virus entry. Lassa virus entry requires a trigger-induced receptor switch. Science 344(6191):1506–1510. https://doi.org/10.1126/science.1252480
Jangra RK, Herbert AS, Li R, Jae LT, Kleinfelter LM, Slough MM, Barker SL, Guardado-Calvo P, Roman-Sosa G, Dieterle ME, Kuehne AI, Muena NA, Wirchnianski AS, Nyakatura EK, Fels JM, Ng M, Mittler E, Pan J, Bharrhan S, Wec AZ, Lai JR, Sidhu SS, Tischler ND, Rey FA, Moffat J, Brummelkamp TR, Wang Z, Dye JM, Chandran K (2018) Protocadherin-1 is essential for cell entry by New World hantaviruses. Nature 563(7732):559–563. https://doi.org/10.1038/s41586-018-0702-1
Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM (2013) RNA-guided human genome engineering via Cas9. Science 339(6121):823–826. https://doi.org/10.1126/science.1232033
Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F (2013) Multiplex genome engineering using CRISPR/Cas systems. Science 339(6121):819–823. https://doi.org/10.1126/science.1231143
Konermann S, Brigham MD, Trevino AE, Joung J, Abudayyeh OO, Barcena C, Hsu PD, Habib N, Gootenberg JS, Nishimasu H, Nureki O, Zhang F (2014) Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature. https://doi.org/10.1038/nature14136
Gilbert LA, Horlbeck MA, Adamson B, Villalta JE, Chen Y, Whitehead EH, Guimaraes C, Panning B, Ploegh HL, Bassik MC, Qi LS, Kampmann M, Weissman JS (2014) Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159(3):647–661. https://doi.org/10.1016/j.cell.2014.09.029
Morgens DW, Deans RM, Li A, Bassik MC (2016) Systematic comparison of CRISPR/Cas9 and RNAi screens for essential genes. Nat Biotechnol 34(6):634–636. https://doi.org/10.1038/nbt.3567
Evers B, Jastrzebski K, Heijmans JP, Grernrum W, Beijersbergen RL, Bernards R (2016) CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes. Nat Biotechnol 34(6):631–633. https://doi.org/10.1038/nbt.3536
Wang T, Wei JJ, Sabatini DM, Lander ES (2014) Genetic screens in human cells using the CRISPR-Cas9 system. Science 343(6166):80–84. https://doi.org/10.1126/science.1246981
Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelsen TS, Heckl D, Ebert BL, Root DE, Doench JG, Zhang F (2014) Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343(6166):84–87. https://doi.org/10.1126/science.1247005
Koike-Yusa H, Li Y, Tan EP, Velasco-Herrera Mdel C, Yusa K (2014) Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat Biotechnol 32(3):267–273. https://doi.org/10.1038/nbt.2800
Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, Smith I, Tothova Z, Wilen C, Orchard R, Virgin HW, Listgarten J, Root DE (2016) Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat Biotechnol 34(2):184–191. https://doi.org/10.1038/nbt.3437
Orchard RC, Sullender ME, Dunlap BF, Balce DR, Doench JG, Virgin HW (2019) Identification of antinorovirus genes in human cells using genome-wide CRISPR activation screening. J Virol 93(1). https://doi.org/10.1128/JVI.01324-18
Dukhovny A, Lamkiewicz K, Chen Q, Fricke M, Jabrane-Ferrat N, Marz M, Jung JU, Sklan EH (2019) A CRISPR activation screen identifies genes that protect against Zika virus infection. J Virol 93(16). https://doi.org/10.1128/JVI.00211-19
Heaton BE, Kennedy EM, Dumm RE, Harding AT, Sacco MT, Sachs D, Heaton NS (2017) A CRISPR activation screen identifies a Pan-avian influenza virus inhibitory host factor. Cell Rep 20(7):1503–1512. https://doi.org/10.1016/j.celrep.2017.07.060
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Zhang, R. (2023). Studying Virus-Host Interactions with CRISPR Technology. In: Bai, F. (eds) West Nile Virus. Methods in Molecular Biology, vol 2585. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2760-0_11
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2760-0_11
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2759-4
Online ISBN: 978-1-0716-2760-0
eBook Packages: Springer Protocols